Clascoterone as a novel treatment for androgenetic alopecia

Clinical and Experimental DermatologyVolume 45, Issue 7 p. 913-914 Viewpoints in dermatology ● Correspondence Clascoterone as a novel treatment for androgenetic alopecia H. Y. Sun, H. Y. Sun Department of Dermatology, Liverpool Hospital, Liverpool, NSW, Australia Faculty of Medicine, University of New South Wales, Sydney, NSW, AustraliaSearch for more papers by this authorD. F. Sebaratnam, Corresponding Author D. F. Sebaratnam deshan@unsw.edu.au orcid.org/0000-0001-5896-8178 Department of Dermatology, Liverpool Hospital, Liverpool, NSW, Australia Faculty of Medicine, University of New South Wales, Sydney, NSW, AustraliaSearch for more papers by this author H. Y. Sun, H. Y. Sun Department of Dermatology, Liverpool Hospital, Liverpool, NSW, Australia Faculty of Medicine, University of New South Wales, Sydney, NSW, AustraliaSearch for more papers by this authorD. F. Sebaratnam, Corresponding Author D. F. Sebaratnam deshan@unsw.edu.au orcid.org/0000-0001-5896-8178 Department of Dermatology, Liverpool Hospital, Liverpool, NSW, Australia Faculty of Medicine, University of New South Wales, Sydney, NSW, AustraliaSearch for more papers by this author First published: 18 May 2020 https://doi.org/10.1111/ced.14292Citations: 4 Conflict of interest: the authors declare that they have no conflicts of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume45, Issue7October 2020Pages 913-914 RelatedInformation